These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 31549879)
1. The Truth Is Unfolding About Transthyretin Cardiac Amyloidosis. Grodin JL; Maurer MS Circulation; 2019 Jul; 140(1):27-30. PubMed ID: 31549879 [No Abstract] [Full Text] [Related]
11. Cardiac transthyretin/leukocyte chemotactic factor (LECT) 2 double amyloidosis in a patient suffering from heart failure. Greulich S; Mahrholdt H; Casadonte R; Steinmüller-Magin L; Latus J; Blessing F; Kriegsmann J; Bekeredjian R; Gawaz M; Klingel K Clin Res Cardiol; 2023 Mar; 112(3):444-449. PubMed ID: 35925392 [No Abstract] [Full Text] [Related]
12. Gene Silencing Therapy in Hereditary (Variant) Transthyretin Cardiac Amyloidosis: A Puzzling Case of Decreasing Pyrophosphate Uptake on Scintigraphy. Smiley DA; Einstein AJ; Mintz A; Shetty M; Chan N; Helmke ST; Bhatia K; Goldner K; Brannagan TH; Santana DD; Maurer MS Circ Cardiovasc Imaging; 2023 Aug; 16(8):e015243. PubMed ID: 37334703 [No Abstract] [Full Text] [Related]
13. Amyloid Cardiomyopathy in the Rare Transthyretin Tyr78Phe Mutation. Tini G; Vianello PF; Gemelli C; Grandis M; Canepa M J Cardiovasc Transl Res; 2019 Dec; 12(6):514-516. PubMed ID: 30604309 [TBL] [Abstract][Full Text] [Related]
14. Transthyretin Cardiac Amyloidosis in Black Americans. Shah KB; Mankad AK; Castano A; Akinboboye OO; Duncan PB; Fergus IV; Maurer MS Circ Heart Fail; 2016 Jun; 9(6):e002558. PubMed ID: 27188913 [TBL] [Abstract][Full Text] [Related]
15. Recognition and Implications of Undiagnosed Cardiac Amyloid Patients in HFpEF Trials. Cheng RK; Maurer MS JACC Heart Fail; 2021 Nov; 9(11):803-806. PubMed ID: 34509407 [No Abstract] [Full Text] [Related]
16. [Transthyretin-related hereditary amyloidosis]. Vionnet J; Pascual M; Kuntzer T; Yerly P; Moradpour D Rev Med Suisse; 2016 Aug; 12(528):1434-1440. PubMed ID: 28675284 [TBL] [Abstract][Full Text] [Related]
17. Cryo-EM structure of a transthyretin-derived amyloid fibril from a patient with hereditary ATTR amyloidosis. Schmidt M; Wiese S; Adak V; Engler J; Agarwal S; Fritz G; Westermark P; Zacharias M; Fändrich M Nat Commun; 2019 Nov; 10(1):5008. PubMed ID: 31676763 [TBL] [Abstract][Full Text] [Related]
18. Hereditary transthyretin amyloidosis associated with a transthyretin variant Thr59Arg. Watanabe T; Obayashi K; Misumi Y; Tasaki M; Shinriki S; Ando T; Akagami T; Ueda M; Yamashita T; Hirotani S; Ando Y Amyloid; 2017 Mar; 24(sup1):119. PubMed ID: 28434332 [No Abstract] [Full Text] [Related]
19. Cryo-EM structure of an ATTRwt amyloid fibril from systemic non-hereditary transthyretin amyloidosis. Steinebrei M; Gottwald J; Baur J; Röcken C; Hegenbart U; Schönland S; Schmidt M Nat Commun; 2022 Oct; 13(1):6398. PubMed ID: 36302762 [TBL] [Abstract][Full Text] [Related]
20. Hereditary transthyretin-related amyloidosis is frequent in polyneuropathy and cardiomyopathy of no obvious aetiology. Skrahina V; Grittner U; Beetz C; Skripuletz T; Juenemann M; Krämer HH; Hahn K; Rieth A; Schaechinger V; Patten M; Tanislav C; Achenbach S; Assmus B; Knebel F; Gingele S; Skrahin A; Hartkamp J; Förster TM; Roesner S; Pereira C; Rolfs A Ann Med; 2021 Dec; 53(1):1787-1796. PubMed ID: 34658264 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]